← SynDRA
SEOCALCITOL
SynDRA canonical compound SYN0028183 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | VDR |
|---|
| Mechanism of action | vitamin D receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- VDR AGONIST
- Vitamin D receptor agonist
- VDR INHIBITOR
Drug classes
- Antineoplastic Agents
- Immunosuppressive Agents
Cross-references
Synonyms
- Eb-1089
- CB-1089
- UNII-Q0OZ0D9223
- EB 1089
- Q0OZ0D9223
- EB1089
- Seocalcitol [INN:BAN]
- (22E,24E)-1alpha,25-dihydroxy-26,27-dimethyl-22,23,24,24a-tetradehydro-24a-homovitamin D3 / (22E,24E)-1alpha,25-dihydroxy-26,27-dimethyl-22,23,24,24a-tetradehydro-24a-homocholecalciferol
- (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R,3E,5E)-7-ethyl-7-hydroxynona-3,5-dien-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
- seocalcitolum
- RefChem:884890
- DTXCID501510003
- MFCD00871599
- Seocalcitol;
- LVLLALCJVJNGQQ-SEODYNFXSA-N
- SEOCALCITOL [MI]
- SEOCALCITOL [INN]
- SEOCALCITOL [MART.]
- SEOCALCITOL [WHO-DD]
- GTPL2777
- orb1706076
- SCHEMBL12028975
- EX-A14570
- LMST03020449
- AKOS024457918
- CS-0398
- HY-32341
- MS-28286
- EB1089, >=98% (HPLC)
- T19559
- BRD-K28456624-001-01-1
- (5Z,7E,22E,24E)-(1S,3R)-26,27-dimethyl-24a-homo-9,10-seco-5,7,10(19),22,24-cholestapentaene-1,3,25-triol
- 22-24-DIENE-24A,26A,27A,TRIHOMO-1ALPHA,25-DIHYDROXYVITAMIN D3
Look up SEOCALCITOL in the interactive SynDRA portal →